On Thursday, Revolution Medicines Inc (NASDAQ: RVMD) was 1.55% up from the session before settling in for the closing price of $36.20. A 52-week range for RVMD has been $29.17 – $62.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -38.52% over the last five years. When this article was written, the company’s average yearly earnings per share was at -28.14%. With a float of $161.67 million, this company’s outstanding shares have now reached $185.90 million.
The firm has a total of 534 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Revolution Medicines Inc (RVMD) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Revolution Medicines Inc stocks. The insider ownership of Revolution Medicines Inc is 13.04%, while institutional ownership is 94.06%. The most recent insider transaction that took place on Mar 20 ’25, was worth 79,008. In this transaction General Counsel of this company sold 2,041 shares at a rate of $38.71, taking the stock ownership to the 57,723 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Officer proposed sale 2,041 for $38.75, making the entire transaction worth $79,089.
Revolution Medicines Inc (RVMD) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.56% during the next five years compared to -27.80% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
You can see what Revolution Medicines Inc (RVMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 14.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.57, a number that is poised to hit -1.10 in the next quarter and is forecasted to reach -4.92 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Analysing the last 5-days average volume posted by the [Revolution Medicines Inc, RVMD], we can find that recorded value of 1.38 million was lower than the volume posted last year of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 95.26%. Additionally, its Average True Range was 1.93.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 24.84%, which indicates a significant decrease from 98.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.78% in the past 14 days, which was higher than the 48.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.30, while its 200-day Moving Average is $44.29. Now, the first resistance to watch is $37.15. This is followed by the second major resistance level at $37.53. The third major resistance level sits at $38.20. If the price goes on to break the first support level at $36.10, it is likely to go to the next support level at $35.43. Should the price break the second support level, the third support level stands at $35.05.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
There are 185,913K outstanding shares of the company, which has a market capitalization of 6.83 billion. As of now, sales total 0 K while income totals -600,090 K. Its latest quarter income was 0 K while its last quarter net income were -194,570 K.
